Potential Treatment for Rare Autoimmune Disorder Adapted From CAR-T Therapy
June 22, 2023 -- Evidence from a small-scale clinical trial suggests that a variation of the advanced blood cancer immunotherapy known as CAR-T could be adapted to treat myasthenia gravis, an autoimmune disorder of the nervous system. The modified... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - June 22, 2023 Category: Pharmaceuticals Source Type: clinical trials
Screening of Serum Exosomal miRNA as a Biomarker for Ocular Muscle Myasthenia Gravis
Condition: Myasthenia Gravis Intervention: Device: Body fluid diagnosis Sponsor: First Affiliated Hospital of Jinan University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 5, 2023 Category: Research Source Type: clinical trials
Rituximab EfFicacy IN MyasthEnia Gravis (REFINE)
Condition: To Assess Whether Rituximab Can Reduce MG-related Functional Impairment Interventions: Drug: Rituximab; Other: Placebo Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2023 Category: Research Source Type: clinical trials
